logo-loader
viewG Medical Innovations Holdings Ltd

G Medical Innovations moving towards US public offering and NASDAQ listing

The company’s Prizma smartphone case transforms a smartphone into a medical monitoring device.

Prizma device
Prizma monitors a full range of vital signs and biometric parameters

G Medical Innovations (ASX:GMV) has engaged a New York based underwriter to assist in the processes towards a US public offering via the NASDAQ stock exchange.

The company will remain listed on the ASX and will proceed with the submission of the F-1 Registration Statement towards a US listing within the next 4 to 5 months.

The listing is subject to satisfaction of all legal and regulatory requirements with NASDAQ, US Securities and Exchange Commission (SEC) and ASX, as well as any shareholder approvals that may be required under the ASX Listing Rules.

The amount of capital to be raised will be determined closer to the proposed offering.

 

G Medical’s key product, Prizma, is a smartphone case that transforms any smartphone into a medical monitoring device.

It is a comprehensive solution that monitors a full range of vital signs and biometric parameters, continuously collecting, consolidating and analysing medical data to detect trends over time.

Prizma allows users to store their medical data in the cloud and share it with third parties including professionals and family.

READ: G Medical Innovations a leading gainer on news of proposed Hong Kong listing of Chinese subsidiary

The company recently revealed its intention to list its Chinese subsidiary on the main board of the Hong Kong Stock Exchange.

G Medical has engaged global investment bank, UOB Kay Hian (Hong Kong) Ltd, as advisers for the listing of Guangzhou Yimei Innovative Medical Science and Technology Co Ltd (GYIMSTC).

GYIMSTC oversees China-based manufacturing for G Medical, ensures all local certifications are met and has worked to build a strong relationship with the China Food and Drug Administration (CFDA).

Quick facts: G Medical Innovations Holdings Ltd

Price: 0.081 AUD

ASX:GMV
Market: ASX
Market Cap: $32.97 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 16/10/18

2 min read